PubMed Health⌕ Search

SEARCH · PubMed Health

Results for “Ferric Compounds”

Explore indexed PubMed citations for clinical trials, systematic reviews and public health research. Read source abstracts and follow each citation to its original PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 109 records · Page 6Linked to original sources
PubMed2004

Melano-macrophage centres in the liver of platyfish, Xiphophorus maculatus, Poeciliidae: Teleostei.

This paper describes the localization and structure of melano-macrophage centres (MMCs) in the liver of platyfish (Xiphophorus maculatus), compares these centres with corresponding structures in the spleen and kidney of various teleosts and gives suggestions about their functions. The MMCs were closely apposed to the endothelial layer of liver venules covered with pancreas tissue, i.e. portal venules, and contained numerous cells displaying large amounts of Prussian blue precipitations in tissue treated with acid ferrocyanide. Thus, these centres were rich in ferric compounds, probably haemosiderin, and are suggested to be involved in the normal storage, relocation and recycling of iron compounds from effete or damaged red blood cells of the portal venule system in this species.

Journal Article↗
PubMed2004

[Safety and usefulness of parenteral iron in the management of anemia due to hip fracture in the elderly].

BACKGROUND AND OBJECTIVE: An important percentage of patients with hip fracture need allogeneic transfusion to resolve their perioperative anemia. Our goal was to determine the safety profile and usefulness of parenteral iron in order to avoid allogeneic transfusions in trochanteric hip fracture (THF). PATIENTS AND METHOD: A pseudo-experimental study was performed comparing a historic THF group (n = 104) with another group (n = 23) treated with parenteral iron (Venofer) (doses of 100 mg). Patients who had primary blood diseases or were receiving anticoagulation therapy were excluded. Age, gender, elapsed time, type of THF (international AO classification), surgical procedure, transfusion procedure and quantity, hemoglobin and hematocrit at days 0 and +2 (if a surgical procedure was not performed) and postoperatively were examined. We also analyzed the morbidity (post-surgical infection) and hospital stay and mortality rate at the first month. RESULTS: We have not observed any adverse reactions upon iron administration. The iron group was transfused less times (39.1% vs. 56.7%) and had lower morbidity (infection) (20.3% vs. 35.4%) (p = 0.04), lower mortality (13% vs. 16.3%), less blood consumption (0.87 vs. 1.31 units) and less stay (13.7 vs. 14.3 days). CONCLUSIONS: Parenteral administration of iron could be a safe and effective way to avoid or reduce allogeneic blood transfusions in THF patients. The reduction in the transfusional rate in the iron treated group is also accompanied by a reduction in the morbidity, infection rate, mortality rate and hospital stay.

Aged↗
PubMed2003

The influence of FeCl3 on the photocatalytic degradation of dissolved azo dyes in aqueous TiO2 suspensions.

The study concerned decolouration of solutions of azo, anionic (Acid Orange 7, Reactive Red 45, Acid Yellow 23) and cationic (Basic Blue 41 and Basic Orange 66) dyes during illumination with UV (lambdamax 366 nm) irradiation in the presence of TiO2 and FeCl3. The process of decolouration during illumination of the solutions studied containing FeCl3 underwent significant intensification in the case of anionic dyes and unfavourable inhibition in case of cationic dyes. It was also observed that FeCl3 had a diverse influence on the adsorption of the dyes studied on TiO2. The adsorption of anionic dyes and decolouration of solutions before the illumination was observed only in the presence of FeCl3. In case of cationic dyes the addition of FeCl3 caused elimination of these phenomena. An additional cause of decolouration of anionic dyes solutions before illumination was the precipitation of their poorly soluble compounds from Fe3+. The processes of degradation and mineralization of the dye that accompanied decolouration of Acid Orange 7 solutions were also observed. It was stated that similarly to the case of Acid Orange 7, the decolouration of the studied anionic dyes' solutions can depend on the concentration of FeCl3, the amount of TiO2 and the initial concentration of the dye in its solution.

Adsorption↗
PubMed2002

Metal complexes of carboxamidrazone analogs as antitubercular agents. 1. Synthesis, X-ray crystal-structures, spectroscopic properties and antimycobacterial activity against Mycobacterium tuberculosis H(37)Rv.

N(1)-Benzylidene-pyridine carboxamidrazones and their metal conjugates have emerged as a new class of potential antimycobacterial agents. Nine such carboxamidrazone analogs (L(1)-L(9)) along with their Cu(II) (MC(1)-MC(9)) and Fe(III) (MC(10)-MC(18)) complexes were synthesized. Single crystal X-ray structures of copper complexes MC(1) and MC(5) were determined which suggest slightly distorted square planer geometries for copper complexes and octahedral geometries for ferric compounds. All compounds were evaluated for their in vitro antimycobacterial activity against Mycobacterium tuberculosis H(37)Rv. The results show 32-64-fold enhancement in antitubercular activity upon copper complexation.

Antitubercular Agents↗
PubMed2000

Parenteral iron use in the management of anemia in end-stage renal disease patients.

Intravenous iron is required by most dialysis patients receiving erythropoietin (EPO) to maintain an adequate hematocrit. In the United States, there are currently two parenteral iron preparations, iron dextran and iron gluconate, approved for such use, and a third product, iron sucrose, is under development. This article reviews each of these products. Each of the iron products increases the efficacy of EPO use in anemia management. There is considerable experience in the United States and elsewhere with the use of iron dextran. Although it is clinically effective, iron dextran is also associated with significant morbidity from both dose-dependent and -independent side effects. The slow release of iron from this complex necessitates a delay in monitoring iron indices after the administration of large doses of iron dextran. Recommended doses of iron sucrose appear very safe with little risk of anaphylactic reactions. Adverse effects are uncommon and not life threatening. If approved for use in the United States, iron sucrose may be a safe and effective alternative to iron dextran. Iron dissociates from iron gluconate quite rapidly and may increase the production of ionized free iron. Iron gluconate may be a safe alternative to iron dextran for patients with severe reactions, including anaphylaxis. The risk of allergic reactions to iron gluconate is very low. The exact place in therapy for the newer iron complexes remains unclear. Currently available data suggest that iron sucrose and iron gluconate may have diminished adverse effect profiles when compared with iron dextran. Additional clinical experience will establish the role for these new iron products.

Anemia, Iron-Deficiency↗
PubMed1997

Are we mismanaging calcium and phosphate metabolism in renal failure?

Secondary hyperparathyroidism and renal osteodystrophy are the consequences of abnormal calcium, phosphate, and calcitriol metabolism ensuing from renal failure. Evidence suggests that calcium balance tends to become negative as we grow older than 35 years of age; however, the current dialysis modalities provide patients regardless of age with excessive calcium during dialysis. Administration of calcitriol in the management of hyperparathyroidism further increases the calcium and phosphate absorption. Furthermore, the current thrice-weekly renal replacement therapies fail to remove the daily absorbed phosphate, and we have to use calcium carbonate as a primary phosphate-binding agent to reduce intestinal phosphate absorption. The large calcium mass transfer and phosphate retention could lead to soft tissue calcification, especially in older end-stage renal disease (ESRD) patients. Consequently, only by maintaining a negative calcium balance during renal replacement therapy can we safely use calcitriol and calcium carbonate for the management of secondary hyperparathyroidism. Recent studies have indicated that phosphate restriction alone independent of plasma calcitriol or calcium can lower plasma parathyroid hormone (PTH) in renal failure and prevent hyperplasia of parathyroid glands. Therefore, phosphate control perhaps is the most important means to prevent secondary hyperparathyroidism. Previous studies have shown that ferric compounds are potent phosphate-binding agents; hence, these compounds warrant further trial in the management of phosphate metabolism in renal failure.

Adult↗
PubMed2002

[Antipublic antibodies and pregnancy: use of iron sucrose in autologous blood donation with cryopreservation].

An autologous blood donation with cryopreservation in a pregnant woman with natural antibody against a high frequency alloantigen is reported. A natural anti Gerbich antibody and a rare erythrocyte phenotype at high risk of polyimmunization was discovered during the third month of pregnancy. This leads to recommend the constitution of an autologous blood reserve. Before first sampling a moderate iron deficiency anaemia (10.3 g.dL-1) was treated with 600 mg of intravenous iron sucrose. Four blood packs of 350 mL were taken; after every sampling 200 mg of iron sucrose were injected intravenously. No maternal or foetal adverse effects occurred. Five weeks before delivery, an autologous blood reserve consisting in 4 cryopreserved red cells packs and 4 fresh frozen plasma was constituted. Epidural analgesia was used for delivery. No haemorrhage occurred. The reserve was not used and remained available for future use (one year for fresh frozen plasma and without limit for red cells).

Adult↗
PubMed1999

[Iron supplementation in preterm infants treated with erythropoietin].

Anemia in premature infants can be prevented by prophylactic treatment with recombinant human erythroprotein (r-huEPO). r-HuEPO as been used for a long time in patients with end-stage renal failure. The main factor which can limit r-HuEPO efficiency is limited iron bioavailability. Adapted iron supplementation is needed when preterm infants receive r-HuEPO in order to avoid the depletion of iron stores. Oral iron supplementation is simple but indigestibility is frequent. Furthermore, the intestinal absorption and utilization of oral iron is limited. Parenteral iron supplementation is possible in infants who are very pre-term as they are parenterally fed during the first weeks of life. There are various preparations of intravenous iron with different physicochemical properties. Toxicity and side-effects of parenteral iron preparations depend on these properties. Two parenteral iron preparations are available in France: iron-saccharate (Venofer) and iron-dextrin (Maltofer). Iron delivery and possible side-effects of these preparations are different and need to be considered before use in preterm infants.

Adult↗
PubMed1999

Quantification aspects of patient studies with 52Fe in positron emission tomography.

Quantification accuracy in positron emission tomography (PET) using non-pure positron emitters, such as 52Fe, may be influenced by gamma radiation emitted in the decay of these isotopes. High-energy positrons, emitted in the decay of the 52Fe-daughter 52mMn, also affect the quantification accuracy. A specific problem of the 52Fe/52mMn decay chain in vivo is that the kinetics of iron and manganese are different, and that PET cannot discriminate between the two nuclides. The effect of the decay properties of 52Fe/52mMn on the performance of PET was investigated using phantoms. Minor degradation in PET performance was found for 52Fe/52mMn compared to the pure low-energy positron emitter 18F. A method is presented to obtain a correction factor for the 52mMn radioactivity in blood. A model for correction of 52mMn-radioactivity in organs, based on existing data on manganese kinetics, is given. The presented corrections are discussed and illustrated in a patient study.

Adult↗
PubMed1993

Catalytic properties of horseradish peroxidase reconstituted with the 8-(hydroxymethyl)- and 8-formylheme derivatives.

Recent studies suggest that 8-(thiomethyl)- and 8-formylheme modifications may be present in, respectively, lactoperoxidase and myeloperoxidase. To examine whether these heme modifications contribute to the unusual catalytic properties of the mammalian peroxidases, we have reconstituted apo-horseradish peroxidase (HRP) with 8-(hydroxymethyl)heme (8HM-HRP) and 8-formylheme (8F-HRP) and have characterized the reconstituted enzymes. Native HRP and 8HM-HRP have identical spectra in the ferric, compound I, and compound II states. In contrast, the Soret band of 8F-HRP is at 417 rather than 402 nm and that of its compound II species is at 436 rather than 416 nm. Compound I was observed as a transient species with 8F-HRP. The rate of formation of compound I was the same for native and 8HM-HRP, but the pseudo-first-order constant for decay of compound I was 0.021 s-1 for 8HM-HRP and 0.010 s-1 for native HRP. The rates of oxidation of guaiacol, iodide, and thioanisole are the same for native HRP and 8HM-HRP but are significantly slower for 8F-HRP. The stereospecificity of thioanisole oxidation is the same for native and 8HM-HRP, but differs for 8F-HRP. For guaiacol, which was studied in detail, Km = 2.3 mM and kcat = 33 s-1 for 8F-HRP versus Km = 1.8 mM and kcat = 104 s-1 for native HRP. 8HM-HRP oxidizes ethylhydrazine and azide to the ethyl and azidyl radicals, respectively, and is simultaneously inactivated. 8F-HRP is also slowly inactivated by ethylhydrazine and azide.(ABSTRACT TRUNCATED AT 250 WORDS)

Anisoles↗
PubMed1982

Isolation and characterization of a new hydroxamic acid from Pseudomonas mildenbergii.

A low molecular weight hydroxamic acid was produced by Pseudomonas mildenbergii in iron-deficient media associated with green fluorescent peptides. The chemical structure of this hydroxamic acid has been investigated for comparison to known iron-binding siderophores. The hydroxamic acid was extracted from lyophilized culture media with ethanol and methanol and crystallized as the hydrochloride. The product had a molecular weight of 202.6 and an empirical formula of C9H11O2N X HCl and contained hydroxylamine nitrogen. The infrared, nuclear magnetic resonance, and mass spectral data suggested that the chemical structure was N-methylphenylacetohydroxamic acid. N-Methylphenylacetohydroxamic acid was synthesized, and its melting point, elemental analysis, and molecular weight were identical with those of the natural product. The compound chelated ferric iron, producing a distinctive iron chelate absorption band at 470 nm. Its relationship to the green fluorescent peptides is discussed.

Benzeneacetamides↗
PubMed2001

A continuous system for Fe0 reduction of nitrobenzene in synthetic wastewater.

Nitrobenzene is a major environmental pollutant, and its degradation is difficultto achieve. Hence, a chemical reduction pretreatment is sought in this research, before the resulting aniline can be treated by enzyme-mediated oxidative polymerization. Zerovalent iron (Fe0) has been successfully employed to reduce nitrobenzene to aniline in synthetic wastewater in both batch and continuous flow reactors. The concentration of nitrobenzene studied was thatwhich would be present in industrial wastewater streams (millimolar, 123 ppm), a concentration range considerably higher than those studied previously with groundwater by other researchers. Anaerobic conditions were maintained in the reactors by including Na2SO3 as an oxygen scavenger in the presence of CoCl2.6H2O, which acted as a catalyst. Batch reactors exhibited adsorption of aniline on the Fe0, which could be described by a langmuir isotherm. A 200 g Fe0 (particle size: 1-2 mm) bed completely converted 1 mM of nitrobenzene flowing upward for about 600 pore-volumes before experiencing flow reduction due to clogging due to corrosion products. Green-black precipitates (Fe0 corrosion products) were formed at the influent end of the column which were identified as maghemite.

Aniline Compounds↗